Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZD526 nasal spray in early Alzheimer's disease (Phase IIa, China)
CTR20260072Phase 2Active
- Sponsor
- Zhihe Dangu
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZD526 in Alzheimer's disease (AD), mild cognitive impairment due to Alzheimer's disease, sponsored by Zhihe Dangu. Started Jan 2026; status: active.
02
Drugs
ZD526
03
Conditions
Alzheimer's disease (AD)mild cognitive impairment due to Alzheimer's disease
Beyond the preview
Go deeper on CTR20260072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260072.